Hello, Welcome to Shine Consultant !
Summit & Event Advisor & Insight Research & Analysis
Guest Information
发布时间: 2021 - 08 - 18
点击次数: 0
Positions: CEO
Company: Fosun Kite Biotechnology Co., Ltd.
个人简介:
Mr. Huang Hai joined Fosun Kite Biotechnology Co., Ltd. (FSK in short) as CEO in December 2020. Based on the combination of independent R&D and technology transfer, FSK is committed to the industrialization and standardization of tumor immune cell therapy technology (CAR-T/TCR-T) in China to benefit Chinese patients. Mr. Huang Hai has nearly 25 years of experience in commercial operations and international management in the pharmaceutical industry. He has worked in multinational pharmaceutical companies such as Pfizer, Sanofi, Roche Diagnostics and Medtronic. Prior to joining FSK, he served as the Chief Operating Officer (COO) of Upjohn China. In 2018, he created China’s first single product with annual sales of US$1.2 billion; and in the environment of mass procurement, he actively developed Upjohn’s future strategy and deployed Internet medical services.
发布时间: 2021 - 08 - 18
点击次数: 0
Positions: Founder,CEO and Board Director
Company: Arctic Vision
个人简介:
Dr. Eddy (Hoi Ti) Wu is the Founder, CEO and Board Director of Arctic Vision. Prior to founding Arctic Vision, Dr. Eddy Wu was Head of Terns China Biotechnology, responsible for directing and overseeing all aspects of R&D activities as well as general management responsibilities in China. Before Terns, Eddy served as Executive Director at Allergan China managing overall R&D, clinical, medical and portfolio strategies in China.  Eddy started his career at Novartis, with stints in Basel, Hong Kong, and Taiwan, holding various positions with increasing responsibilities. At the Novartis Headquarters in Basel, he served as Regional Medical Director and Head of Health Economics & Outcome Research (HEOR) for AMAC (Asia-Pacific, Middle East and African Countries), China & Japan.  Eddy graduated with a Bachelor’s degree and a PhD in Biochemistry from Hong Kong University of Science and Technology (HKUST).
发布时间: 2021 - 08 - 18
点击次数: 0
Positions: COO of Biosion; President of Biosion USA
Company: Biosion, Inc.
个人简介:
Dr. Davis is currently the Chief Operating Officer of Biosion, Inc. & President, Biosion, USA, Inc.  Dr. Davis brings to Biosion over 30 years of global Research & Development experience in the biotech and pharmaceutical industries. Dr. Davis joined Biosion from Frontage Laboratories, Inc., where he served as Chief Business Officer, leading the company to a very successful IPO in May of 2019. Prior to Frontage, Dr. Davis worked with Johnson & Johnson where he served as Vice President and Head of Biologics Development Sciences and China Biologics Leader in the Janssen Biotherapeutics division of Janssen R&D, LLC since 2001. During his tenure in J&J, Hugh and his team were instrumental in the development and approval of many biologic therapies including Remicade, Stelara, Simponi, Sylvant, Darzalex and Tremfya.  Prior to J&J, Hugh led the Pharmacodynamics & Exploratory Research Laboratory in the Clinical Pharmacology Unit at Glaxo SmithKline from 1996 to 2001.  Dr. Davis holds a Ph.D. degree in Biochemistry from Villanova University and completed his Post-Doctoral training at Centocor, Inc.
发布时间: 2021 - 08 - 18
点击次数: 0
Positions: CEO
Company: Shanghai BravoBio Co., Ltd.
个人简介:
Dr. Wu Ke is the Founder and CEO of BravoBio & BravoVax. He has more than 30 years of experiences in biopharm industry and had successfully developed 7 products being marketed in China. He also has 20+ granted patents from China or PCT. He was Executive President of Shanghai Zerun Biotechnology. Prior to start Zerun, he was Director of R&D in Wuhan Institute of Biological Products, China National Biotec Group (CNBG). He holds a PhD degree in Immunology, also alumnus of both China Europe International Business School (CEIBS) and Cheung Kong Graduate School of Business (CKGSB). He is a Specially-appointed Professor by Hubei Provincial Government, also Visiting Professor in Hubei University, etc..